KAZIA THERAPEUTICS LTD
Oncology-focused drug development firm advancing anti-cancer candidates for brain cancers in trials.
KZIA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- THREE INTERNATIONAL TOWERS LEVEL 24,, 2000 SYDNEY NSW
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kazia Therapeutics Limited is an oncology-focused drug development company specializing in pharmaceutical research and development. The company is dedicated to creating innovative, high-impact drugs for cancer. Its lead program is paxalisib, an investigational drug being developed to treat various forms of cancer, particularly brain cancers. As a clinical-stage biotechnology firm, Kazia focuses on advancing its pipeline of anti-cancer drug candidates through rigorous clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all KAZIA THERAPEUTICS LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KAZIA THERAPEUTICS LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KAZIA THERAPEUTICS LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
